Inventor · disambiguated record
Ulrich Hommel
Also filed as: HOMMEL ULRICH
11 granted patents·2 pending applications·127 citations·filing 1998–2013
89Inventor score
Top patents by PatentIndex Score
13 records- 0189US9468661B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 18, 2016·17 cites·18 claims
- 0289US9085555B2Complement pathway modulators and uses thereofALTMANN EVA·Filed 2012·Granted Jul 21, 2015·26 cites·8 claims
- 0383US6399599B1Substituted 2-oxo-1,4-diazacycloalkanesNOVARTIS AG·Filed 2000·Granted Jun 4, 2002·17 cites·17 claims
- 0479US9388199B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Jul 12, 2016·5 cites·14 claims
- 0577US9815819B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 14, 2017·4 cites·20 claims
- 0676US9550755B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Jan 24, 2017·3 cites·4 claims
- 0775US6818638B2Melvinolin derivativesNOVARTIS AG·Filed 2002·Granted Nov 16, 2004·10 cites·12 claims
- 0873US6630492B1Lymphocyte function antigen-1 antagonistsNOVARTIS AG·Filed 1998·Granted Oct 7, 2003·41 cites·11 claims
- 0972US9487483B2Complement pathway modulators and uses thereofNOVARTIS AG·Filed 2013·Granted Nov 8, 2016·2 cites·17 claims
- 1072US9464081B2Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Granted Oct 11, 2016·2 cites·13 claims
- 1142US2015191462A1Pyrrolidine derivatives and their use as complement pathway modulatorsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1242US2002037895A1Mevinolin derivativesFiled 2001·Application pending·0 cites
- 1339US7700605B22-cyano-pyrimidines and-triazines as cysteine protease inhibitorsNOVARTIS AG·Filed 2006·Granted Apr 20, 2010·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →